125 related articles for article (PubMed ID: 10690721)
1. In vivo proton magnetic resonance spectroscopy of central neurocytomas.
Kim DG; Choe WJ; Chang KH; Song IC; Han MH; Jung HW; Cho BK
Neurosurgery; 2000 Feb; 46(2):329-33; discussion 333-4. PubMed ID: 10690721
[TBL] [Abstract][Full Text] [Related]
2. Automated MR spectroscopy of intra- and extraventricular neurocytomas.
Ueda F; Suzuki M; Matsui O; Uchiyama N
Magn Reson Med Sci; 2007; 6(2):75-81. PubMed ID: 17690537
[TBL] [Abstract][Full Text] [Related]
3. Proton MR spectroscopy of central neurocytoma using short and long echo time: new proofs for the existence of glycine and glutamate.
Liu M; Yue Q; Isobe T; Matsumura A; Li J; Yang Z; Quan H; Xing H; Gong Q
Acad Radiol; 2012 Jul; 19(7):779-84. PubMed ID: 22503892
[TBL] [Abstract][Full Text] [Related]
4. 3-T proton magnetic resonance spectroscopy of central neurocytoma: 3 case reports and review of the literature.
Chuang MT; Lin WC; Tsai HY; Liu GC; Hu SW; Chiang IC
J Comput Assist Tomogr; 2005; 29(5):683-8. PubMed ID: 16163043
[TBL] [Abstract][Full Text] [Related]
5. In vivo and in vitro MR spectroscopic profile of central neurocytomas.
Jayasundar R; Shah T; Vaishya S; Singh VP; Sarkar C
J Magn Reson Imaging; 2003 Feb; 17(2):256-60. PubMed ID: 12541233
[TBL] [Abstract][Full Text] [Related]
6. MRS characterization of central neurocytomas using glycine.
Shah T; Jayasundar R; Singh VP; Sarkar C
NMR Biomed; 2011 Dec; 24(10):1408-13. PubMed ID: 21465595
[TBL] [Abstract][Full Text] [Related]
7. Heritability heightens brain metabolite differences in schizophrenia.
Fukuzako H
J Neuropsychiatry Clin Neurosci; 2000; 12(1):95-7. PubMed ID: 10678520
[TBL] [Abstract][Full Text] [Related]
8. Noninvasive evaluation of malignancy of brain tumors with proton MR spectroscopy.
Shimizu H; Kumabe T; Tominaga T; Kayama T; Hara K; Ono Y; Sato K; Arai N; Fujiwara S; Yoshimoto T
AJNR Am J Neuroradiol; 1996 Apr; 17(4):737-47. PubMed ID: 8730195
[TBL] [Abstract][Full Text] [Related]
9. Metabolic assessment of the human pons by in vivo proton magnetic resonance spectroscopy.
Guan JT; Xu XH; Geng YQ; Yu XJ; Wu RH
Brain Res; 2008 Aug; 1227():221-5. PubMed ID: 18602897
[TBL] [Abstract][Full Text] [Related]
10. Analysis of cerebral structural changes in systemic lupus erythematosus by proton MR spectroscopy.
Sibbitt WL; Haseler LJ; Griffey RH; Hart BL; Sibbitt RR; Matwiyoff NA
AJNR Am J Neuroradiol; 1994 May; 15(5):923-8. PubMed ID: 8059662
[TBL] [Abstract][Full Text] [Related]
11. [Clinical application of proton magnetic resonance spectroscopy for differential diagnosis of pediatric posterior fossa tumors].
Zakrzewski K; Kreisel J; Polis L; Nowosławska E; Liberski PP; Biegański T
Neurol Neurochir Pol; 2001; 35 Suppl 5():19-25. PubMed ID: 11935675
[TBL] [Abstract][Full Text] [Related]
12. Cerebral metabolism in experimental hydrocephalus: an in vivo 1H and 31P magnetic resonance spectroscopy study.
Braun KP; van Eijsden P; Vandertop WP; de Graaf RA; Gooskens RH; Tulleken KA; Nicolay K
J Neurosurg; 1999 Oct; 91(4):660-8. PubMed ID: 10507389
[TBL] [Abstract][Full Text] [Related]
13. Proton magnetic resonance spectroscopy in the evaluation of children with congenital heart disease and acute central nervous system injury.
Ashwal S; Holshouser BA; Hinshaw DB; Schell RM; Bailey L
J Thorac Cardiovasc Surg; 1996 Aug; 112(2):403-14. PubMed ID: 8751509
[TBL] [Abstract][Full Text] [Related]
14. Proton magnetic resonance spectroscopy in primary and secondary progressive multiple sclerosis.
Cucurella MG; Rovira A; Río J; Pedraza S; Tintoré MM; Montalbán X; Alonso J
NMR Biomed; 2000 Apr; 13(2):57-63. PubMed ID: 10797633
[TBL] [Abstract][Full Text] [Related]
15. Noninvasive evaluation of the malignant potential of intracranial meningiomas performed using proton magnetic resonance spectroscopy.
Shino A; Nakasu S; Matsuda M; Handa J; Morikawa S; Inubushi T
J Neurosurg; 1999 Dec; 91(6):928-34. PubMed ID: 10584837
[TBL] [Abstract][Full Text] [Related]
16. MR imaging and proton MR spectroscopic studies in Sjögren-Larsson syndrome: characterization of the leukoencephalopathy.
Willemsen MA; Van Der Graaf M; Van Der Knaap MS; Heerschap A; Van Domburg PH; Gabreëls FJ; Rotteveel JJ
AJNR Am J Neuroradiol; 2004 Apr; 25(4):649-57. PubMed ID: 15090362
[TBL] [Abstract][Full Text] [Related]
17. Early time course of N-acetylaspartate, creatine and phosphocreatine, and compounds containing choline in the brain after acute stroke. A proton magnetic resonance spectroscopy study.
Gideon P; Henriksen O; Sperling B; Christiansen P; Olsen TS; Jørgensen HS; Arlien-Søborg P
Stroke; 1992 Nov; 23(11):1566-72. PubMed ID: 1440704
[TBL] [Abstract][Full Text] [Related]
18. Reduction in temporal N-acetylaspartate and creatine (or choline) ratio in temporal lobe epilepsy: does this 1H-magnetic resonance spectroscopy finding mean poor seizure control?
Mendes-Ribeiro JA; Soares R; Simões-Ribeiro F; Guimarães ML
J Neurol Neurosurg Psychiatry; 1998 Oct; 65(4):518-22. PubMed ID: 9771777
[TBL] [Abstract][Full Text] [Related]
19. In vivo proton magnetic resonance spectroscopy of brain tumors.
Fountas KN; Kapsalaki EZ; Gotsis SD; Kapsalakis JZ; Smisson HF; Johnston KW; Robinson JS; Papadakis N
Stereotact Funct Neurosurg; 2000; 74(2):83-94. PubMed ID: 11251398
[TBL] [Abstract][Full Text] [Related]
20. Proton magnetic resonance spectroscopy of bipolar disorder versus intermittent explosive disorder in children and adolescents.
Davanzo P; Yue K; Thomas MA; Belin T; Mintz J; Venkatraman TN; Santoro E; Barnett S; McCracken J
Am J Psychiatry; 2003 Aug; 160(8):1442-52. PubMed ID: 12900307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
